February 2026 in “Frontiers in Immunology” This review highlights the role of the brain–gut–skin axis in systemic inflammatory skin conditions, revealing potential interventions like microbiome-directed treatments and integrative therapies, though emphasizes the need for more robust clinical validation.
January 2026 in “Frontiers in Molecular Biosciences” This study identified a four-gene loop as a non-invasive biomarker that selectively activates in alopecia areata, providing a precise target for JAK inhibitor treatments.
October 2025 in “Frontiers in Immunology” This study explores the potential of platelet-rich plasma (PRP) as a novel adjuvant therapy for eczema, positing that it may alleviate inflammation, enhance skin barrier function, and reduce recurrence.
January 2023 in “Frontiers research topics” This article describes the Frontiers journal series, highlighting its open-access approach and tiered publishing system, but it presents no new empirical findings.
April 2026 in “Frontiers in Immunology” This study concluded that the CXCL12–CXCR4 signaling pathway significantly contributes to hair loss in androgenetic alopecia and alopecia areata by promoting inflammation and fibrosis, whereas inhibiting this pathway can restore hair growth and follicle health.
March 2026 in “Frontiers in Medicine” This study provides a framework for understanding different types of alopecias based on immune privilege collapse at specific follicular sites, revealing distinct patterns in immune effector programs and stromal influences depending on the alopecia type.
March 2026 in “Frontiers in Medicine” This study reviews advances in targeted therapies for moderate-severe dermatological conditions like plaque psoriasis and atopic dermatitis, reporting on newly approved treatments and highlighting the need for further innovations in managing rare inflammatory skin diseases through emerging laboratory techniques and trials.
March 2026 in “Frontiers in Immunology” This review highlights the complex role of leukocyte migration in both driving inflammation and facilitating its resolution, suggesting that targeted modulation of this process could improve therapeutic strategies for inflammatory diseases.
December 2025 in “Frontiers in Medicine” This case report presents the first instance of a pediatric alopecia areata patient switching from baricitinib to ritlecitinib, demonstrating favorable clinical outcomes, suggesting a potential new treatment pathway for children with severe cases of this condition.
December 2025 in “Frontiers in Immunology” This review highlights that disturbances in neuroimmune communication, particularly between sympathetic nerves and macrophages, may contribute to autoimmune diseases like rheumatoid arthritis and type 1 diabetes, and suggests potential therapeutic avenues by restoring this communication in preclinical and early clinical studies.
July 2025 in “Frontiers in Medicine” This study found that topical immunotherapy is effective for treating severe alopecia areata, though patient responses can vary, highlighting the importance of individualized treatment approaches and prolonged therapy to optimize outcomes.
October 2024 in “Frontiers in Nutrition” This study found that patients with alopecia, particularly alopecia areata and female pattern hair loss, often have vitamin D deficiency, suggesting that screening for vitamin D could benefit these patients.
May 2024 in “Frontiers in Medicine” Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.
March 2024 in “Frontiers in Endocrinology” In this study, a bidirectional Mendelian randomization analysis found a causal link between alopecia areata and hypothyroidism, indicating that each condition may influence the other, while no similar relationship was observed between androgenetic alopecia and hypothyroidism.
2 citations
,
June 2025 in “Frontiers in Public Health” This study reported that regular mole examinations and UVR protection are crucial for skin cancer prevention, particularly for individuals with fair skin, inflammatory skin conditions, diabetes, and those on photosensitizing medications.
3 citations
,
January 2022 in “Cutis” This study focused on developing workflows for conducting virtual hair and scalp examinations during teledermatology visits, especially for patients with skin of color, due to the rise in alopecia consultations during the COVID-19 pandemic.
3 citations
,
August 2021 in “Cutis” This review examines CAM approaches for atopic dermatitis, psoriasis, and alopecia areata, providing dermatologists with current insights but includes no new clinical findings.
This study found that human placental extract significantly improved melasma, chronic ulcers, and alopecia areata without major adverse effects, suggesting its effectiveness and safety for these conditions.
In this dermatopathologic examination of an 88-year-old man with progressive eyelash loss and scale on the eyelids, the best diagnosis was suggested as either alopecia areata, alopecia mucinosa, or folliculotropic mycosis.
This case report presented the successful treatment of a patient with alopecia universalis using tofacitinib.
Some TikTok hair loss remedies like rosemary oil, onion juice, and garlic gel show promise, but more research is needed and they might delay proper treatment.
This article discusses treatments for androgenetic alopecia and alopecia areata, focusing on finasteride and minoxidil, and reports no new clinical results.
157 citations
,
April 1994 in “Clinical endocrinology” Androgens can cause hair growth in some areas and hair loss on the scalp.
July 2025 in “International Journal of Pharmacology and Clinical Research” This study surveyed individuals and found that awareness and understanding of thyroid disorders, particularly symptom recognition and the importance of early detection, are low, highlighting the need for targeted public health initiatives to improve knowledge and management.
1 citations
,
August 2018 in “Journal of The American Academy of Dermatology” Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.
1 citations
,
January 2019 in “Via Medica Journals” This case report describes the diagnosis and treatment challenges of Graham-Little syndrome, a rare condition involving cicatricial alopecia on the scalp, non-scarring hair loss in certain areas, and keratosis pilaris-like eruptions.
3 citations
,
July 2025 in “BIOMED natural and applied science” This systematic review synthesizes the current state of drug repurposing, revealing its potential in various therapeutic areas like oncology and infectious diseases through insights from mechanistic studies and real-world evidence, and discusses emerging tools and challenges in the field.
2 citations
,
June 2018 in “Journal of Aesthetic Nursing” This review discusses the progress and ongoing challenges in implementing regulations for cosmetic interventions, reporting no new results and highlighting areas that still need improvement.
April 2026 in “International Journal of Drug Delivery Technology” This study among college-going girls in Tamil Nadu found that the average age of menarche was 12.84 years, with associations to factors like family history, lifestyle, and residential settings, highlighting a generational decline in menarche age and the need for further public health research.
September 2025 in “Clinical Cosmetic and Investigational Dermatology” This study in Jordan found that topical corticosteroid use is common and often involves creams obtained without prescriptions, with only 61.3% of users aware of potential side effects, highlighting a need for better public education and regulation to prevent misuse.